CD24 and neoplasm: Also, in animal models of breast cancer and renal cell cancer, it has been demonstrated that platelets tend to adhere with increased affinity to angiogenic vessels, mediated by the upregulation of CD24 on tumor cells, thus releasing their pro-angiogenic content in the tumor microenvironment (27).